Search

Your search keyword '"Hoepelman, Andy I. M."' showing total 680 results
Start Over Author "Hoepelman, Andy I. M."
680 results on '"Hoepelman, Andy I. M."'

3. Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Author

Axfors, Cathrine, Schmitt, Andreas M., Janiaud, Perrine, van’t Hooft, Janneke, Abd-Elsalam, Sherief, Abdo, Ehab F., Abella, Benjamin S., Akram, Javed, Amaravadi, Ravi K., Angus, Derek C., Arabi, Yaseen M., Azhar, Shehnoor, Baden, Lindsey R., Baker, Arthur W., Belkhir, Leila, Benfield, Thomas, Berrevoets, Marvin A. H., Chen, Cheng-Pin, Chen, Tsung-Chia, Cheng, Shu-Hsing, Cheng, Chien-Yu, Chung, Wei-Sheng, Cohen, Yehuda Z., Cowan, Lisa N., Dalgard, Olav, de Almeida e Val, Fernando F., de Lacerda, Marcus V. G., de Melo, Gisely C., Derde, Lennie, Dubee, Vincent, Elfakir, Anissa, Gordon, Anthony C., Hernandez-Cardenas, Carmen M., Hills, Thomas, Hoepelman, Andy I. M., Huang, Yi-Wen, Igau, Bruno, Jin, Ronghua, Jurado-Camacho, Felipe, Khan, Khalid S., Kremsner, Peter G., Kreuels, Benno, Kuo, Cheng-Yu, Le, Thuy, Lin, Yi-Chun, Lin, Wu-Pu, Lin, Tse-Hung, Lyngbakken, Magnus Nakrem, McArthur, Colin, McVerry, Bryan J., Meza-Meneses, Patricia, Monteiro, Wuelton M., Morpeth, Susan C., Mourad, Ahmad, Mulligan, Mark J., Murthy, Srinivas, Naggie, Susanna, Narayanasamy, Shanti, Nichol, Alistair, Novack, Lewis A., O’Brien, Sean M., Okeke, Nwora Lance, Perez, Léna, Perez-Padilla, Rogelio, Perrin, Laurent, Remigio-Luna, Arantxa, Rivera-Martinez, Norma E., Rockhold, Frank W., Rodriguez-Llamazares, Sebastian, Rolfe, Robert, Rosa, Rossana, Røsjø, Helge, Sampaio, Vanderson S., Seto, Todd B., Shahzad, Muhammad, Soliman, Shaimaa, Stout, Jason E., Thirion-Romero, Ireri, Troxel, Andrea B., Tseng, Ting-Yu, Turner, Nicholas A., Ulrich, Robert J., Walsh, Stephen R., Webb, Steve A., Weehuizen, Jesper M., Velinova, Maria, Wong, Hon-Lai, Wrenn, Rebekah, Zampieri, Fernando G., Zhong, Wu, Moher, David, Goodman, Steven N., Ioannidis, John P. A., and Hemkens, Lars G.

Published
2024
Full Text
View/download PDF

6. Author Correction 2024: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z)

Author

Medische Staf Intensive Care, Infection & Immunity, MS Reumatologie/Immunologie/Infectie, MS Interne Geneeskunde, MS Dermatologie/Allergologie, MS Infectieziekten, Axfors, Cathrine, Schmitt, Andreas M, Janiaud, Perrine, Van't Hooft, Janneke, Abd-Elsalam, Sherief, Abdo, Ehab F, Abella, Benjamin S, Akram, Javed, Amaravadi, Ravi K, Angus, Derek C, Arabi, Yaseen M, Azhar, Shehnoor, Baden, Lindsey R, Baker, Arthur W, Belkhir, Leila, Benfield, Thomas, Berrevoets, Marvin A H, Chen, Cheng-Pin, Chen, Tsung-Chia, Cheng, Shu-Hsing, Cheng, Chien-Yu, Chung, Wei-Sheng, Cohen, Yehuda Z, Cowan, Lisa N, Dalgard, Olav, de Almeida E Val, Fernando F, de Lacerda, Marcus V G, de Melo, Gisely C, Derde, Lennie, Dubee, Vincent, Elfakir, Anissa, Gordon, Anthony C, Hernandez-Cardenas, Carmen M, Hills, Thomas, Hoepelman, Andy I M, Huang, Yi-Wen, Igau, Bruno, Jin, Ronghua, Jurado-Camacho, Felipe, Khan, Khalid S, Kremsner, Peter G, Kreuels, Benno, Kuo, Cheng-Yu, Le, Thuy, Lin, Yi-Chun, Lin, Wu-Pu, Lin, Tse-Hung, Lyngbakken, Magnus Nakrem, McArthur, Colin, McVerry, Bryan J, Meza-Meneses, Patricia, Monteiro, Wuelton M, Morpeth, Susan C, Mourad, Ahmad, Mulligan, Mark J, Murthy, Srinivas, Naggie, Susanna, Narayanasamy, Shanti, Nichol, Alistair, Novack, Lewis A, O'Brien, Sean M, Okeke, Nwora Lance, Perez, Léna, Perez-Padilla, Rogelio, Perrin, Laurent, Remigio-Luna, Arantxa, Rivera-Martinez, Norma E, Rockhold, Frank W, Rodriguez-Llamazares, Sebastian, Rolfe, Robert, Rosa, Rossana, Røsjø, Helge, Sampaio, Vanderson S, Seto, Todd B, Shahzad, Muhammad, Soliman, Shaimaa, Stout, Jason E, Thirion-Romero, Ireri, Troxel, Andrea B, Tseng, Ting-Yu, Turner, Nicholas A, Ulrich, Robert J, Walsh, Stephen R, Webb, Steve A, Weehuizen, Jesper M, Velinova, Maria, Wong, Hon-Lai, Wrenn, Rebekah, Zampieri, Fernando G, Zhong, Wu, Moher, David, Goodman, Steven N, Ioannidis, John P A, Hemkens, Lars G, Medische Staf Intensive Care, Infection & Immunity, MS Reumatologie/Immunologie/Infectie, MS Interne Geneeskunde, MS Dermatologie/Allergologie, MS Infectieziekten, Axfors, Cathrine, Schmitt, Andreas M, Janiaud, Perrine, Van't Hooft, Janneke, Abd-Elsalam, Sherief, Abdo, Ehab F, Abella, Benjamin S, Akram, Javed, Amaravadi, Ravi K, Angus, Derek C, Arabi, Yaseen M, Azhar, Shehnoor, Baden, Lindsey R, Baker, Arthur W, Belkhir, Leila, Benfield, Thomas, Berrevoets, Marvin A H, Chen, Cheng-Pin, Chen, Tsung-Chia, Cheng, Shu-Hsing, Cheng, Chien-Yu, Chung, Wei-Sheng, Cohen, Yehuda Z, Cowan, Lisa N, Dalgard, Olav, de Almeida E Val, Fernando F, de Lacerda, Marcus V G, de Melo, Gisely C, Derde, Lennie, Dubee, Vincent, Elfakir, Anissa, Gordon, Anthony C, Hernandez-Cardenas, Carmen M, Hills, Thomas, Hoepelman, Andy I M, Huang, Yi-Wen, Igau, Bruno, Jin, Ronghua, Jurado-Camacho, Felipe, Khan, Khalid S, Kremsner, Peter G, Kreuels, Benno, Kuo, Cheng-Yu, Le, Thuy, Lin, Yi-Chun, Lin, Wu-Pu, Lin, Tse-Hung, Lyngbakken, Magnus Nakrem, McArthur, Colin, McVerry, Bryan J, Meza-Meneses, Patricia, Monteiro, Wuelton M, Morpeth, Susan C, Mourad, Ahmad, Mulligan, Mark J, Murthy, Srinivas, Naggie, Susanna, Narayanasamy, Shanti, Nichol, Alistair, Novack, Lewis A, O'Brien, Sean M, Okeke, Nwora Lance, Perez, Léna, Perez-Padilla, Rogelio, Perrin, Laurent, Remigio-Luna, Arantxa, Rivera-Martinez, Norma E, Rockhold, Frank W, Rodriguez-Llamazares, Sebastian, Rolfe, Robert, Rosa, Rossana, Røsjø, Helge, Sampaio, Vanderson S, Seto, Todd B, Shahzad, Muhammad, Soliman, Shaimaa, Stout, Jason E, Thirion-Romero, Ireri, Troxel, Andrea B, Tseng, Ting-Yu, Turner, Nicholas A, Ulrich, Robert J, Walsh, Stephen R, Webb, Steve A, Weehuizen, Jesper M, Velinova, Maria, Wong, Hon-Lai, Wrenn, Rebekah, Zampieri, Fernando G, Zhong, Wu, Moher, David, Goodman, Steven N, Ioannidis, John P A, and Hemkens, Lars G

Published
2024

7. Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Author

Axfors, Cathrine, Schmitt, Andreas M., Janiaud, Perrine, van’t Hooft, Janneke, Abd-Elsalam, Sherief, Abdo, Ehab F., Abella, Benjamin S., Akram, Javed, Amaravadi, Ravi K., Angus, Derek C., Arabi, Yaseen M., Azhar, Shehnoor, Baden, Lindsey R., Baker, Arthur W., Belkhir, Leila, Benfield, Thomas, Berrevoets, Marvin A. H., Chen, Cheng-Pin, Chen, Tsung-Chia, Cheng, Shu-Hsing, Cheng, Chien-Yu, Chung, Wei-Sheng, Cohen, Yehuda Z., Cowan, Lisa N., Dalgard, Olav, de Almeida e Val, Fernando F., de Lacerda, Marcus V. G., de Melo, Gisely C., Derde, Lennie, Dubee, Vincent, Elfakir, Anissa, Gordon, Anthony C., Hernandez-Cardenas, Carmen M., Hills, Thomas, Hoepelman, Andy I. M., Huang, Yi-Wen, Igau, Bruno, Jin, Ronghua, Jurado-Camacho, Felipe, Khan, Khalid S., Kremsner, Peter G., Kreuels, Benno, Kuo, Cheng-Yu, Le, Thuy, Lin, Yi-Chun, Lin, Wu-Pu, Lin, Tse-Hung, Lyngbakken, Magnus Nakrem, McArthur, Colin, McVerry, Bryan J., Meza-Meneses, Patricia, Monteiro, Wuelton M., Morpeth, Susan C., Mourad, Ahmad, Mulligan, Mark J., Murthy, Srinivas, Naggie, Susanna, Narayanasamy, Shanti, Nichol, Alistair, Novack, Lewis A., O’Brien, Sean M., Okeke, Nwora Lance, Perez, Léna, Perez-Padilla, Rogelio, Perrin, Laurent, Remigio-Luna, Arantxa, Rivera-Martinez, Norma E., Rockhold, Frank W., Rodriguez-Llamazares, Sebastian, Rolfe, Robert, Rosa, Rossana, Røsjø, Helge, Sampaio, Vanderson S., Seto, Todd B., Shahzad, Muhammad, Soliman, Shaimaa, Stout, Jason E., Thirion-Romero, Ireri, Troxel, Andrea B., Tseng, Ting-Yu, Turner, Nicholas A., Ulrich, Robert J., Walsh, Stephen R., Webb, Steve A., Weehuizen, Jesper M., Velinova, Maria, Wong, Hon-Lai, Wrenn, Rebekah, Zampieri, Fernando G., Zhong, Wu, Moher, David, Goodman, Steven N., Ioannidis, John P. A., and Hemkens, Lars G.

Published
2021
Full Text
View/download PDF

8. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Author

Axfors, Cathrine, Schmitt, Andreas M., Janiaud, Perrine, van’t Hooft, Janneke, Abd-Elsalam, Sherief, Abdo, Ehab F., Abella, Benjamin S., Akram, Javed, Amaravadi, Ravi K., Angus, Derek C., Arabi, Yaseen M., Azhar, Shehnoor, Baden, Lindsey R., Baker, Arthur W., Belkhir, Leila, Benfield, Thomas, Berrevoets, Marvin A. H., Chen, Cheng-Pin, Chen, Tsung-Chia, Cheng, Shu-Hsing, Cheng, Chien-Yu, Chung, Wei-Sheng, Cohen, Yehuda Z., Cowan, Lisa N., Dalgard, Olav, de Almeida e Val, Fernando F., de Lacerda, Marcus V. G., de Melo, Gisely C., Derde, Lennie, Dubee, Vincent, Elfakir, Anissa, Gordon, Anthony C., Hernandez-Cardenas, Carmen M., Hills, Thomas, Hoepelman, Andy I. M., Huang, Yi-Wen, Igau, Bruno, Jin, Ronghua, Jurado-Camacho, Felipe, Khan, Khalid S., Kremsner, Peter G., Kreuels, Benno, Kuo, Cheng-Yu, Le, Thuy, Lin, Yi-Chun, Lin, Wu-Pu, Lin, Tse-Hung, Lyngbakken, Magnus Nakrem, McArthur, Colin, McVerry, Bryan J., Meza-Meneses, Patricia, Monteiro, Wuelton M., Morpeth, Susan C., Mourad, Ahmad, Mulligan, Mark J., Murthy, Srinivas, Naggie, Susanna, Narayanasamy, Shanti, Nichol, Alistair, Novack, Lewis A., O’Brien, Sean M., Okeke, Nwora Lance, Perez, Léna, Perez-Padilla, Rogelio, Perrin, Laurent, Remigio-Luna, Arantxa, Rivera-Martinez, Norma E., Rockhold, Frank W., Rodriguez-Llamazares, Sebastian, Rolfe, Robert, Rosa, Rossana, Røsjø, Helge, Sampaio, Vanderson S., Seto, Todd B., Shahzad, Muhammad, Soliman, Shaimaa, Stout, Jason E., Thirion-Romero, Ireri, Troxel, Andrea B., Tseng, Ting-Yu, Turner, Nicholas A., Ulrich, Robert J., Walsh, Stephen R., Webb, Steve A., Weehuizen, Jesper M., Velinova, Maria, Wong, Hon-Lai, Wrenn, Rebekah, Zampieri, Fernando G., Zhong, Wu, Moher, David, Goodman, Steven N., Ioannidis, John P. A., and Hemkens, Lars G.

Published
2021
Full Text
View/download PDF

11. Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based Regimen.

Author

Stam, Arjen J., Buchholtz, Ninée V. E. J., Bierman, Wouter F. W., van Crevel, Reinout, Hoepelman, Andy I. M., Claassen, Mark A. A., Ammerlaan, Heidi S. M., van Welzen, Berend J., van Kasteren, Marjo E. E., van Lelyveld, Steven F. L., de Jong, Dorien, Tesselaar, Kiki, van Luin, Matthijs, Nijhuis, Monique, Wensing, Annemarie M. J., and Team, LOWERIT Study

Subjects
VIREMIA, VIRAL mutation, PATIENT compliance, VIRAL replication, DRUG resistance
Abstract

There is an ongoing debate regarding whether low-level viremia (LLV), in particular persistent LLV, during HIV treatment with optimal adherence originates from low-level viral replication, viral production, or both. We performed an observational study in 30 individuals with LLV who switched to a boosted darunavir (DRV)-based therapy. In-depth virological analyses were used to characterize the viral population and the (activity) of the viral reservoir. Immune activation was examined using cell-bound and soluble markers. The primary outcome was defined as the effect on HIV-RNA and was categorized by responders (<50 cp/mL) or non-responders (>50 cp/mL). At week 24, 53% of the individuals were considered responders, 40% non-responders, and 7% could not be assigned. Sequencing showed no evolution or selection of drug resistance in the non-responders. Production of defective virus with mutations in either the protease (D25N) or RT active site contributed to persistent LLV in two individuals. We show that in about half of the study participants, the switch to a DRV-based regimen resulted in a viral response indicative of ongoing low-level viral replication as the cause of LLV before the switch. Our data confirm that in clinical management, high genetic barrier drugs like DRV are a safe choice, irrespective of the source of LLV. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

17. New filovirus disease classification and nomenclature

Author

Kuhn, Jens H., Adachi, Takuya, Adhikari, Neill K. J., Arribas, Jose R., Bah, Ibrahima Elhadj, Bausch, Daniel G., Bhadelia, Nahid, Borchert, Matthias, Brantsæter, Arne Broch, Brett-Major, David M., Burgess, Timothy H., Chertow, Daniel S., Chute, Christopher G., Cieslak, Theodore J., Colebunders, Robert, Crozier, Ian, Davey, Richard T., de Clerck, Hilde, Delgado, Rafael, Evans, Laura, Fallah, Mosoka, Fischer, II, William A., Fletcher, Tom E., Fowler, Robert A., Grünewald, Thomas, Hall, Andy, Hewlett, Angela, Hoepelman, Andy I. M., Houlihan, Catherine F., Ippolito, Giuseppe, Jacob, Shevin T., Jacobs, Michael, Jakob, Robert, Jacquerioz, Frederique A., Kaiser, Laurent, Kalil, Andre C., Kamara, Rashidatu F., Kapetshi, Jimmy, Klenk, Hans-Dieter, Kobinger, Gary, Kortepeter, Mark G., Kraft, Colleen S., Kratz, Thomas, Bosa, Henry S. Kyobe, Lado, Marta, Lamontagne, François, Lane, H. Cliff, Lobel, Leslie, Lutwama, Julius, Lyon, III, G. Marshall, Massaquoi, Moses B. F., Massaquoi, Thomas A., Mehta, Aneesh K., Makuma, Vital Mondonge, Murthy, Srinivas, Musoke, Tonny Seikikongo, Muyembe-Tamfum, Jean-Jacques, Nakyeyune, Phiona, Nanclares, Carolina, Nanyunja, Miriam, Nsio-Mbeta, Justus, O’Dempsey, Tim, Pawęska, Janusz T., Peters, Clarence J., Piot, Peter, Rapp, Christophe, Renaud, Bertrand, Ribner, Bruce, Sabeti, Pardis C., Schieffelin, John S., Slenczka, Werner, Soka, Moses J., Sprecher, Armand, Strong, James, Swanepoel, Robert, Uyeki, Timothy M., van Herp, Michel, Vetter, Pauline, Wohl, David A., Wolf, Timo, Wolz, Anja, Wurie, Alie H., and Yoti, Zabulon

Published
2019
Full Text
View/download PDF

23. Integrated analysis of viral blips, residual viremia, and associated factors in people with HIV: Results from a retrospective cohort study.

Author

Oomen, Patrick G. A., Dijkstra, Suzan, Hofstra, L. Marije, Nijhuis, Monique M., Verbon, Annelies, Mudrikova, Tania, Wensing, Annemarie M. J., Hoepelman, Andy I. M., and Van Welzen, Berend J.

Subjects
NON-nucleoside reverse transcriptase inhibitors, HIV-positive persons, REVERSE transcriptase inhibitors, VIREMIA, COHORT analysis
Abstract

The etiology of viral blips is not yet fully elucidated. One of the hypotheses is that blips reflect variations in residual viremia (RV) near the detectability threshold. In this study, we evaluated whether RV is associated with viral blips and which factors are associated with RV. All treatment regimens in 2010–2020 consisting of two nucleos(‐t)ide reverse transcriptase inhibitors and one anchor (integrase strand transfer inhibitor [INSTI], non‐nucleoside reverse transcriptase inhibitor [NNRTI], or protease inhibitor [PI]) in people with HIV (PWH) were evaluated for RV (detectable viremia <50 cp/mL) and blips (isolated viral loads [VLs] 50–499 cp/mL between measurements <50 cp/mL). All medical records were reviewed and regimens in which a VL ≥ 50 cp/mL was deemed to result from non‐adherence (based on the documented conclusion by the treating physician) were excluded. Factors associated with blips and RV were identified using generalized linear mixed models. In total, 24 518 VLs from 1658 PWH were analyzed. VLs were measured during INSTI‐ (n = 5119; 20.9%), PI‐ (n = 8935; 36.4%), and NNRTI‐use (n = 10 464; 42.7%). VLs were categorized as blips in 1.4% (n = 332). The 24,186 non‐blip VLs were RNAneg (no RV) (n = 15 326; 63.4%), 1–19 cp/mL (n = 6318; 26.1%), 20–49 cp/mL (n = 1620; 6.7%), or <50 cp/mL with an unknown RV level (n = 922; 3.8%). In 193/1658 PWH (11.6%), the RV level was RNAneg in all VLs assessed. RV 1–19 cp/mL and 20–49 cp/mL (vs. RNAneg) were significantly associated with subsequent viral blips (respective odds ratio 2.66 and 4.90 [95% confidence intervals: 1.98–3.58 and 3.41–7.04]). Zenith VL and use of PIs (vs. INSTIs/NNRTIs) were associated with higher RV and blip odds. This large cohort study showed that blips were associated with higher preceding RV. Both the anchor type and factors previously linked to the latent viral reservoir were associated with RV, suggesting blips having a multifactorial origin. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

32. Nitrofurantoin 100 mg versus 50 mg prophylaxis for urinary tract infections, a cohort study

Author

Unit Opleiding Aios, Epi Infectieziekten Team 1, Infection & Immunity, JC onderzoeksprogramma Infectieziekten, Longziekten, HAG Infectieziekten, MS Infectieziekten, Epi Infectieziekten, Ten Doesschate, Thijs, Hendriks, Kelly, van Werkhoven, Cornelis H, van der Hout, Evelien C, Platteel, Tamara N, Groenewegen, Irene A M, Muller, Anouk E, Hoepelman, Andy I M, Bonten, Marc J M, Geerlings, Suzanne E, Unit Opleiding Aios, Epi Infectieziekten Team 1, Infection & Immunity, JC onderzoeksprogramma Infectieziekten, Longziekten, HAG Infectieziekten, MS Infectieziekten, Epi Infectieziekten, Ten Doesschate, Thijs, Hendriks, Kelly, van Werkhoven, Cornelis H, van der Hout, Evelien C, Platteel, Tamara N, Groenewegen, Irene A M, Muller, Anouk E, Hoepelman, Andy I M, Bonten, Marc J M, and Geerlings, Suzanne E

Published
2022

36. No increased risk of mature B-cell non-Hodgkin lymphoma after Q fever detected: results from a 16-year ecological analysis of the Dutch population incorporating the 2007–2010 Q fever outbreak

Author

Weehuizen, Jesper M, primary, van Roeden, Sonja E, additional, Hogewoning, Sander J, additional, van der Hoek, Wim, additional, Bonten, Marc J M, additional, Hoepelman, Andy I M, additional, Bleeker-Rovers, Chantal P, additional, Wever, Peter C, additional, and Oosterheert, Jan Jelrik, additional

Published
2022
Full Text
View/download PDF

49. Still New Chronic Q Fever Cases Diagnosed 8 Years After a Large Q Fever Outbreak

Author

Buijs, S.B., Bleeker-Rovers, C.P., Roeden, Sonja E. van, Kampschreur, Linda M., Hoepelman, Andy I. M., Wever, Peter C., Oosterheert, Jan Jelrik, Buijs, S.B., Bleeker-Rovers, C.P., Roeden, Sonja E. van, Kampschreur, Linda M., Hoepelman, Andy I. M., Wever, Peter C., and Oosterheert, Jan Jelrik

Abstract

Item does not contain fulltext

Published
2021

50. The prognostic value of serological titres for clinical outcomes during treatment and follow-up of patients with chronic Q fever

Author

Buijs, S.B., Roeden, Sonja E. van, Werkhoven, C.H. van, Hoepelman, Andy I. M., Wever, Peter C., Bleeker-Rovers, C.P., Oosterheert, Jan Jelrik, Buijs, S.B., Roeden, Sonja E. van, Werkhoven, C.H. van, Hoepelman, Andy I. M., Wever, Peter C., Bleeker-Rovers, C.P., and Oosterheert, Jan Jelrik

Abstract

Contains fulltext : 237200.pdf (Publisher’s version ) (Open Access)

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results